Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$6.96B |
| 2 |
Salesforce
CRM
|
+$2.62B |
| 3 |
UnitedHealth
UNH
|
+$2.16B |
| 4 |
Meta Platforms (Facebook)
META
|
+$2.12B |
| 5 |
Boeing
BA
|
+$1.8B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$8.99B |
| 2 |
GE Aerospace
GE
|
+$5.58B |
| 3 |
Abbott
ABT
|
+$2.84B |
| 4 |
Micron Technology
MU
|
+$1.85B |
| 5 |
Canadian Natural Resources
CNQ
|
+$1.73B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.1% |
| 2 | Healthcare | 15.12% |
| 3 | Industrials | 12.22% |
| 4 | Consumer Discretionary | 11.82% |
| 5 | Communication Services | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Cencora
COR
$60B
| $640M | 0.14% |
2,840,117
+163,365
| +6% | +$37.8M |
|
127
Las Vegas Sands
LVS
$29.6B
| $623M | 0.14% |
14,083,602
+12,680,320
| +904% | +$592M |
|
128
Saia
SAIA
$9.73B
| $603M | 0.13% |
1,271,702
+202,370
| +19% | +$94.3M |
|
129
Woodward
WWD
$21.4B
| $602M | 0.13% |
3,450,898
-175,194
| -5% | -$29.8M |
|
130
Icon
ICLR
$12.9B
| $596M | 0.13% |
1,900,180
-300,237
| -14% | -$94.1M |
|
131
Sherwin-Williams
SHW
$87.4B
| $591M | 0.13% |
1,981,459
-83,688
| -4% | -$25.9M |
|
132
Regeneron Pharmaceuticals
REGN
$82.2B
| $587M | 0.13% |
558,787
+164,605
| +42% | +$160M |
|
133
ConocoPhillips
COP
$153B
| $578M | 0.13% |
5,054,448
-1,639,825
| -24% | -$199M |
|
134
Caterpillar
CAT
$393B
| $577M | 0.13% |
1,730,972
-289,128
| -14% | -$100M |
|
135
Haemonetics
HAE
$4.16B
| $572M | 0.13% |
6,915,209
+240,458
| +4% | +$21.2M |
|
|
MRSH
136
Marsh
MRSH
$90.1B
| $564M | 0.12% |
2,674,606
+412,596
| +18% | +$84.8M |
|
137
Altria Group
MO
$107B
| $549M | 0.12% |
12,042,136
-2,796
| -0% | -$124K |
|
138
First Solar
FSLR
$24.4B
| $538M | 0.12% |
2,387,281
-555,309
| -19% | -$121M |
|
139
CME Group
CME
$94.3B
| $529M | 0.12% |
2,689,021
-951,245
| -26% | -$197M |
|
140
Humana
HUM
$46.7B
| $525M | 0.12% |
+1,405,646
| New | +$475M |
|
141
Principal Financial Group
PFG
$24.4B
| $518M | 0.11% |
6,603,902
+1,604
| +0% | +$130K |
|
142
General Motors
GM
$76.1B
| $501M | 0.11% |
10,773,745
-3,086,804
| -22% | -$139M |
|
143
Monster Beverage
MNST
$90.1B
| $490M | 0.11% |
19,620,248
-1,376,800
| -7% | -$36.5M |
|
144
Sysco
SYY
$40.5B
| $490M | 0.11% |
6,863,384
+251,292
| +4% | +$18.8M |
|
145
Qorvo
QRVO
$8.67B
| $487M | 0.11% |
4,193,133
-398,852
| -9% | -$42.5M |
|
146
Eastman Chemical
EMN
$8.29B
| $485M | 0.11% |
4,952,102
+440,636
| +10% | +$43.7M |
|
147
British American Tobacco
BTI
$120B
| $474M | 0.1% |
15,321,220
+8,355
| +0.1% | +$254K |
|
148
CAVA Group
CAVA
$8.09B
| $458M | 0.1% |
4,940,652
-370,683
| -7% | -$28.6M |
|
149
Ferrari
RACE
$71.6B
| $458M | 0.1% |
1,120,280
-209,434
| -16% | -$87.1M |
|
150
LPL Financial
LPLA
$29.7B
| $440M | 0.1% |
1,577,102
-20,034
| -1% | -$5.44M |
|
Similar funds
Capital Research Global Investors's Q2 2024 Portfolio in Review
As of Q2 2024, Capital Research Global Investors held 450 positions worth $456B, up 3.1% from $442B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Capital Research Global Investors's Q2 2024 filing shows 40 new, 179 increased, 147 reduced and 36 closed positions. Its largest new stake was Oracle: 11,571,987 shares worth $1.63B. The largest sale was Broadcom, an estimated $8.99B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.
- Capital Research Global Investors's largest Q2 2024 buy was Oracle: 11,571,987 shares worth $1.63B.
- Capital Research Global Investors added most to Apple in Q2 2024, an estimated $6.96B increase.
- Capital Research Global Investors's biggest Q2 2024 reduction was Broadcom, cutting an estimated $8.99B.
- Capital Research Global Investors fully exited Norwegian Cruise Line in Q2 2024, selling an estimated $1.19B.
- Capital Research Global Investors's ten largest holdings make up 34% of its $456B portfolio in Q2 2024.
- Capital Research Global Investors opened 40 new positions and closed 36 in Q2 2024.
- Capital Research Global Investors's portfolio value rose 3.1% quarter-over-quarter to $456B.
Based on Capital Research Global Investors's 13F filing for Q2 2024, filed 13 Aug 2024.